FreeCME

Psychopharmacology

Jointly provided by Postgraduate Institute for Medicine and Global Medical Education.

Supported by an independent educational grant from Alkermes, Forest Pharmaceuticals, and Sunovion Pharmaceuticals.

Scroll to the Bottom of this Information to Begin this Course

Release date: February 15, 2015

Valid through: February 16, 2016

Specialty: Psychiatric Medicine

Target Audience

This activity has been designed to meet the educational needs of Primary Care Physicians, Internists, Neurologists, Psychiatrists, nurse practitioners, registered nurses, and other specialists involved in the care of patients.

This program consists of 6 continuing education activites.

Click the links below to review the activity launch pages containing full disclosure information.

Pharmacological Treatment of Anxiety Disorders

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses0.9 contact hours
    Designated for 0.6 contact hours of pharmacotherapy credit for APRNs.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Implement evidence based pharmacotherapy for anxiety disorders.
  • Provide appropriate care and counsel for patients and their families.

 

Pharmacotherapy of Depression: State of the Art and Future Directions

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses1.0 contact hours
    Designated for 0.4 contact hours of pharmacotherapy credit for APRNs.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Evaluate the role of neuromodulatory treatments in treatment resistant depression
  • Provide appropriate care and counsel for patients and their families

 

Pharmacotherapy of Bipolar Disorders

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses1.0 contact hours
    Designated for 0.4 contact hours of pharmacotherapy credit for APRNs.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Implement evidence based pharmacotherapy for mood disorders
  • Provide appropriate care and counsel for patients and their families

 

Treating Schizophrenia in the Real World to Improve Outcomes

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses1.0 contact hours
    Designated for 0.5 contact hours of pharmacotherapy credit for APRNs.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Implement evidence based pharmacotherapy for schizophrenia
  • Provide appropriate care and counsel for patients and their families

 

Pharmacotherapy in the Patient with Dementia

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses0.9 contact hours
    Designated for 0.4 contact hours of pharmacotherapy credit for APRNs.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Assess the latest advances in the management of dementia
  • Provide appropriate care and counsel for patients and their families

 

Pharmacotherapy of Alcohol Use Disorders

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)
  • Nurses1.0 contact hours
    Designated for 0.6 contact hours of pharmacotherapy credit for APRNs.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Employ the appropriate treatment of alcohol dependence
  • Provide appropriate care and counsel for patients and their families